Scandion Oncology
Overcoming cancer drug resistance
Navbar
Research & Development
Pipeline
Clinical Development
Science
Cancer drug resistance
Technology Platform
SCO-101
News & Press
Press releases
Investors
Share information
Financial calendar
Financial Reports
Annual reports
Interim reports
Presentations
Business development
Analyst Coverage
Prospectuses
Subscription warrants
Rights Issue 2024
Rights Issue 2022
Rights Issue 2020
Rights Issue 2019
Subscription Warrant (SCOL TO 1)
IPO 2018
Corporate governance
General meetings
Skip to content
Event
Q4 2023 Report
« All Events
This event has passed.
28 February, 2024
«
Investor/R&D event
Annual report 2023
»
Add to calendar
Google Calendar
iCalendar
Outlook 365
Outlook Live
Details
Date:
28 February, 2024
Event Category:
Financial Events
